Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Filamon LTD
Atavistik Bio, Inc
PMV Pharmaceuticals, Inc
AstraZeneca
Alterome Therapeutics, Inc.
Eli Lilly and Company
BeOne Medicines
Monte Rosa Therapeutics, Inc
Psyence Australia Pty Ltd
ViroMissile, Inc.
Novartis
AstraZeneca
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Eli Lilly and Company
Angiex, Inc.
Sapience Therapeutics
IDEAYA Biosciences
Daiichi Sankyo
Guerbet
Eli Lilly and Company
Oscotec Inc.
Adela, Inc
Second Life Therapeutics
Apollo Therapeutics Ltd
Innate Pharma
Acerand Therapeutics Limited
MOMA Therapeutics
Complement Theory Inc.
Tanabe Pharma America, Inc.
NeoTX Therapeutics Ltd.
NantCell, Inc.
Incyte Corporation
AVM Biotechnology Inc
Pfizer
Exelixis
AstraZeneca
Senhwa Biosciences, Inc.
858 Therapeutics, Inc.
Novita Pharmaceuticals, Inc.
Eli Lilly and Company
NextPoint Therapeutics, Inc.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
ModeX Therapeutics, An OPKO Health Company
TransThera Sciences (Nanjing), Inc.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Merus B.V.
Tempus AI
AtlasMedx, Incorporated